Person profile
Address
South San Francisco, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
NGM BIOPHARMACEUTICALS INC
8 Apr 24
4
Denali Therapeutics Inc.
15 Feb 24
144
Denali Therapeutics Inc.
14 Feb 24
144
Denali Therapeutics Inc.
13 Feb 24
4
Denali Therapeutics Inc.
12 Jan 24
144
Denali Therapeutics Inc.
10 Jan 24
4
Denali Therapeutics Inc.
9 Jan 24
144
Denali Therapeutics Inc.
5 Jan 24
4
Denali Therapeutics Inc.
5 Jan 24
4
Denali Therapeutics Inc.
25 Aug 23
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
5 Apr 24 | NGM Ngm Biopharmaceuticals | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 20.66 | 39,515 | 816.38 k | 0 |
5 Apr 24 | NGM Ngm Biopharmaceuticals | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 17.24 | 19,619 | 338.23 k | 0 |
5 Apr 24 | NGM Ngm Biopharmaceuticals | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 13.35 | 24,222 | 323.36 k | 0 |
5 Apr 24 | NGM Ngm Biopharmaceuticals | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 3.69 | 78,407 | 289.32 k | 0 |
14 Feb 24 | DNLI Denali Therapeutics | Common Stock | Sell | Dispose S | No | Yes | 17.79 | 1,405 | 24.99 k | 143,605 |
13 Feb 24 | DNLI Denali Therapeutics | Common Stock | Sell | Dispose S | No | No | 17.29 | 2,784 | 48.14 k | 145,010 |
10 Jan 24 | DNLI Denali Therapeutics | Common Stock | Sell | Dispose S | No | Yes | 19.02 | 4,668 | 88.79 k | 147,794 |
5 Jan 24 | DNLI Denali Therapeutics | Common Stock | Sell | Dispose S | Yes | No | 19.43 | 9,972 | 193.76 k | 198,777 |
3 Jan 24 | DNLI Denali Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 53,720 | 0.00 | 162,434 |
3 Jan 24 | DNLI Denali Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 20.33 | 161,160 | 3.28 mm | 161,160 |